A Study to Investigate the Effects of CBP-307 on the Heart Rate-corrected QT Interval (QTc) in Healthy Subjects
Clinical trial NCT04818229 · COMPLETED
Trial details
- NCT number
- NCT04818229
- Sponsor
- Connect Biopharma Australia Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2022-03-20
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.